Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

Close menu
  • News
  • Products
  • Contact
    • Request More Information
    • Journalists
    • GDPR

    DolCas Biotech Obtains its First Non-GMO Project Verified Label for MMP-50®


    News provided by

    DolCas Biotech

    13 Sep, 2023, 14:00 IDT

    Share this article

    Share this article


    The company announces the opening of a satellite office in London

    LANDING, N.J., Sept. 13, 2023 /PRNewswire/ -- DolCas Biotech, LLC obtains its first Non-GMO Project-verified label for MMP-50®, a cold-processed, DNA-verified, and clinically researched New Zealand green lipped mussel extract for human and pet health. MMP-50 is one of seven clinically researched ingredients in the innovative company's portfolio, and while MMP-50 is the first to receive the backing of the prestigious certification, CEO and founder, K. G. Rao affirms the company's plans to pursue the certification across its portfolio.

    The transparency efforts the Non-GMO Project spearheaded on the food front has translated to the supplement market. Recent Natural Marketing Institute data reveal that a non-GMO certification seal rates as high as a USDA Certified Organic seal, both leading the supplement purchasing decisions of consumers at 69%. A recent Nutraceuticals World article sharing the NMI data listed these two categories as leading by 10+ percentage points above USP, fair-trade, and NSF.

    DolCas voluntarily submitted MMP-50 for compliance evaluation with the Non-GMO Project standard. "Given the pristine conditions of the New Zealand waters, the mussel farming practices that are tightly regulated by the local authorities, and the consistent quality of this ingredient, we were confident that MMP-50 would meet the high standards and rigorous accounting required of the project's product verification program," conveyed Rao.

    MMP50™ is produced from fresh, unopened mussels supplied directly from the ocean farm to the factory with no middle-man or traveling delay. Further, the shell extraction step is time/temperature controlled to maintain biological activity throughout the processing.

    "This verification is just one of the components of the impressive marketing suite backing MMP-50," adds Shavon Jackson-Michel, Director of Medical and Scientific Affairs for DolCas. "Each batch of MMP-50 is tested for DNA to validate exclusive Perna canaliculus—Green Lipped Mussel—sourcing, against adulterated and counterfeit mussel preparations from blue, black, and even brown shell varieties. The proprietary, cold-processed whole-mussel extract boasts a unique, fully-preserved spectrum of synergistically active compounds, including protein, lipids, anti-inflammatory omega-3s, carbohydrates—including joint supportive glycosaminoglycans—and a host of vitamins, minerals, and other micronutrients. This distinguishes MMP-50 from other green lipped mussel extracts in the market that are either cooked, or solvent-extracted, concentrated lipid fractions, or defatted formulations that upcycle remnant components of the green lipped mussel after the lipids have been isolated."

    Non-GMO project verification further sets MMP-50 apart in the market in combination with the formulation's published clinical support in humans, dogs, and horses for reducing joint discomfort and limitation, promoting extended active lifestyles/activity, and supporting joint function. Each batch of MMP-50 produced is further assayed for bioactivity and screened against nine relevant, joint-destructive enzymes, known as matrix metalloproteinases (MMPs). MMP-50 is proven to consistently inhibit them by a minimum of 50%. "We wanted to do our part in the heavy lifting of formulation/ingredient selection for our customers," adds Rao. "This certification provides them with an unassailable marketing advantage.

    DolCas additionally obtained the Aquaculture Stewardship Council's (ASC) certificate of sustainability, meeting health and environmental hallmarks in the cultivation of the fish sourced for its Morikol, tripeptide collagen formulation for beauty and joint health. Like the Non-GMO Verified Project, the ASC certificate is the most highly merited of third-party credentialing in its category. "Sourcing of our tilapia and catfish from ASC-certified aquaculture facilities is another proud differentiator and brand confidence booster, as savvy consumers seek more friendly ways care for their health and the environment" adds Dr. Jackson-Michel.

    In other news, for DolCas Biotech's European customers requiring more time-zone specific and direct communication with the company regarding its brands and turnkey business options, to the company announces the opening of a satellite office in London, headed by Zachin Rao.

    Visit us at Supply Side West 2023, Oct. 23-27, Las Vegas, booth #2445.

    For more information:

    Company Contact:
    DolCas Biotech, LLC
    Dr. Shavon Jackson-Michel 
    Director of Medical & Scientific Affairs
    Tel: 973-347-1958 ext. 217
    Email: [email protected]
    Web: www.dolcas-biotech.com

    Press Contact:
    NUTRiPR
    Liat Simha
    Tel: +972-9-974-2893
    Email: [email protected]
    Website: www.nutripr.com
    Twitter: @LiatSimha

    Photo - https://mma.prnewswire.com/media/2209620/DolCas_Biotech_MMP_50.jpg

    SOURCE DolCas Biotech

    Modal title

    Also from this source

    Curcugen® Goes Beyond the Capsule into Two Formats Consumers Crave

    Curcugen® Goes Beyond the Capsule into Two Formats Consumers Crave

    Nutraceutical leader DolCas Biotech, LLC is elevating curcumin supplementation beyond the pill by bringing its Curcugen® "full spectrum" curcuminoid...

    DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format

    DolCas Biotech: Beauty-From-Within Collagen Tripeptide Gets New Delivery Format

    DolCas Biotech, LLC, a leader in clinically researched nutraceutical ingredients, announces the introduction of a new format for its Morikol® marine...

    More Releases From This Source

    Contact PR Newswire

    • +972-77-2005042
      from 8 AM - 11 PM IL

    Global Sites

    • APAC
    • APAC - Traditional Chinese
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany

     

    • India
    • Indonesia
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland

     

    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Global Sites
    • Asia
    • Brazil
    • Canada
    • Csezh
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italie
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States
    +972-77-2005042
    from 8 AM - 11 PM IL
    • Terms of Use
    • Privacy Policy
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.